A. Gilbert

发表

Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.

L. Carin, Rob Lambkin-Williams, A. Hero, 2009, Cell host & microbe.

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

Tao Dong, Adrian V. S. Hill, Tom Havelock, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model.

J. Oxford, Rob Lambkin-Williams, A. Gilbert, 2014, The Journal of infectious diseases.

A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

Rob Lambkin-Williams, A. Gilbert, H. Schuitemaker, 2021, The Journal of infectious diseases.

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

J. Oxford, Rob Lambkin-Williams, A. Gilbert, 2012, Nature Medicine.

An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection

J. Oxford, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections.

Rob Lambkin-Williams, A. Zaas, C. Woods, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Minimal Transmission in an Influenza A (H3N2) Human Challenge-Transmission Model with Exposure Events in a Controlled Environment

Paul Jacob, Bueno de Mesquita, Rob Lambkin-Williams, 2019, SSRN Electronic Journal.

Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases

Rob Lambkin-Williams, A. Mann, A. Gilbert, 2020, Influenza and other respiratory viruses.

Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification

Timothy B. Stockwell, Gavin J. D. Smith, Rob Lambkin-Williams, 2016, Journal of Virology.

The Effect of Influenza Virus on the Human Oropharyngeal Microbiome

Rob Lambkin-Williams, A. Mann, A. Gilbert, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effective rate of influenza reassortment is limited during human infection

Christopher J. R. Illingworth, Timothy B. Stockwell, Gavin J. D. Smith, 2017, PLoS pathogens.

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics

Rob Lambkin-Williams, A. Mann, A. Gilbert, 2018, Respiratory Research.

The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2018, BMC Research Notes.

Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study.

J. Oxford, Rob Lambkin-Williams, A. Gilbert, 2011, The Journal of infectious diseases.

Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination

J. Oxford, Rob Lambkin-Williams, A. Mann, 2013, PloS one.

Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge

Ricardo Henao, Rob Lambkin-Williams, A. Mann, 2016, Clinical and experimental immunology.

The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

Andrew P. Catchpole, Daniel J. Fullen, Nicolas Noulin, 2018, BMC Research Notes.